Allison J Carroll1, Mark D Huffman, Lihui Zhao, David R Jacobs, Jesse C Stewart, Catarina I Kiefe, Kiang Liu, Brian Hitsman. 1. From the Department of Preventive Medicine (Carroll, Huffman, Zhao, Liu, Hitsman), Northwestern University Feinberg School of Medicine, Chicago, Illinois; Division of Epidemiology and Community Health (Jacobs), School of Public Health, University of Minnesota, Minneapolis, Minnesota; Department of Psychology (Stewart), Indiana University-Purdue University Indianapolis, Indiana; and Department of Population and Quantitative Health Sciences (Kiefe), University of Massachusetts Medical School, Boston, Massachusetts.
Abstract
OBJECTIVE: The aim of the study was to evaluate associations between 15-year trajectories of co-occurring depressive symptoms and smoking with biomarkers of cardiovascular disease at year 15. METHODS: In the Coronary Artery Risk Development in Young Adults study, we modeled trajectories of depressive symptoms (Center for Epidemiologic Studies-Depression scale [CES-D]) and smoking (cigarettes per day [CPD]) among 3614 adults followed from year 0 (ages 18-30 years) through year 15 (ages 33-45 years). Biomarkers of inflammation (high-sensitivity C-reactive protein), oxidative stress (superoxide dismutase, F2-isoprostanes), and endothelial dysfunction (soluble intercellular adhesion molecule 1, soluble P-selectin) were assessed at year 15. We conducted separate linear regression analyses with CES-D trajectory, CPD trajectory, and their interaction with each of the five biomarkers. RESULTS: The sample was 56% women, 47% black, and 40 years old on average at year 15. The CES-D trajectory by CPD trajectory interaction was not associated with any of the biomarkers (all p's > .01). Removing the interaction term, CES-D trajectory was associated with inflammation: higher levels of high-sensitivity C-reactive protein were observed in the subthreshold (β = 0.57, p = .004) and increasing depressive symptoms (β = 1.36, p < .001) trajectories compared with the no depression trajectory. CPD trajectory was associated with oxidative stress and endothelial dysfunction: compared with never smokers, heavy smokers had significantly higher levels of F2-isoprostanes (β = 6.20, p = .001), soluble intercellular adhesion molecule 1 (β = 24.98, p < .001), and soluble P-selectin (β = 2.91, p < .001). CONCLUSIONS: Co-occurring depressive symptoms and smoking do not seem to synergistically convey risk for cardiovascular disease via processes of inflammation, oxidative stress, or endothelial dysfunction. Nonetheless, these results advance our understanding of the complex relationships between modifiable risk factors and chronic disease.
OBJECTIVE: The aim of the study was to evaluate associations between 15-year trajectories of co-occurring depressive symptoms and smoking with biomarkers of cardiovascular disease at year 15. METHODS: In the Coronary Artery Risk Development in Young Adults study, we modeled trajectories of depressive symptoms (Center for Epidemiologic Studies-Depression scale [CES-D]) and smoking (cigarettes per day [CPD]) among 3614 adults followed from year 0 (ages 18-30 years) through year 15 (ages 33-45 years). Biomarkers of inflammation (high-sensitivity C-reactive protein), oxidative stress (superoxide dismutase, F2-isoprostanes), and endothelial dysfunction (soluble intercellular adhesion molecule 1, soluble P-selectin) were assessed at year 15. We conducted separate linear regression analyses with CES-D trajectory, CPD trajectory, and their interaction with each of the five biomarkers. RESULTS: The sample was 56% women, 47% black, and 40 years old on average at year 15. The CES-D trajectory by CPD trajectory interaction was not associated with any of the biomarkers (all p's > .01). Removing the interaction term, CES-D trajectory was associated with inflammation: higher levels of high-sensitivity C-reactive protein were observed in the subthreshold (β = 0.57, p = .004) and increasing depressive symptoms (β = 1.36, p < .001) trajectories compared with the no depression trajectory. CPD trajectory was associated with oxidative stress and endothelial dysfunction: compared with never smokers, heavy smokers had significantly higher levels of F2-isoprostanes (β = 6.20, p = .001), soluble intercellular adhesion molecule 1 (β = 24.98, p < .001), and soluble P-selectin (β = 2.91, p < .001). CONCLUSIONS: Co-occurring depressive symptoms and smoking do not seem to synergistically convey risk for cardiovascular disease via processes of inflammation, oxidative stress, or endothelial dysfunction. Nonetheless, these results advance our understanding of the complex relationships between modifiable risk factors and chronic disease.
Authors: Julie A Pasco; Geoffrey C Nicholson; Lana J Williams; Felice N Jacka; Margaret J Henry; Mark A Kotowicz; Hans G Schneider; Brian E Leonard; Michael Berk Journal: Br J Psychiatry Date: 2010-11 Impact factor: 9.319
Authors: Raghupathy Paranthaman; Adam S Greenstein; Alistair S Burns; J Kennedy Cruickshank; Anthony M Heagerty; Alan Jackson; Rayaz A Malik; Marietta L J Scott; Robert C Baldwin Journal: Biol Psychiatry Date: 2010-07-15 Impact factor: 13.382
Authors: Viola Vaccarino; B Delia Johnson; David S Sheps; Steven E Reis; Sheryl F Kelsey; Vera Bittner; Thomas Rutledge; Leslee J Shaw; George Sopko; C Noel Bairey Merz Journal: J Am Coll Cardiol Date: 2007-11-05 Impact factor: 24.094
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng Journal: Lancet Date: 2004 Sep 11-17 Impact factor: 79.321
Authors: Frances Wensley; Pei Gao; Stephen Burgess; Stephen Kaptoge; Emanuele Di Angelantonio; Tina Shah; James C Engert; Robert Clarke; George Davey-Smith; Børge G Nordestgaard; Danish Saleheen; Nilesh J Samani; Manjinder Sandhu; Sonia Anand; Mark B Pepys; Liam Smeeth; John Whittaker; Juan Pablo Casas; Simon G Thompson; Aroon D Hingorani; John Danesh Journal: BMJ Date: 2011-02-15
Authors: Bridgette M Brawner; Lloyd M Talley; Jillian L Baker; Lisa Bowleg; Tiffany B Dominique; Daiquiri Y Robinson; Barbara Riegel Journal: Ethn Dis Date: 2022-07-21 Impact factor: 2.006
Authors: Allison J Carroll; Mark D Huffman; Lihui Zhao; David R Jacobs; Jesse C Stewart; Catarina I Kiefe; Wendy Brunner; Kiang Liu; Brian Hitsman Journal: J Affect Disord Date: 2019-09-09 Impact factor: 6.533